Skip to main content
Kopran Ltd. logo

Kopran Ltd. — Investor Relations & Filings

Ticker · KOPRAN ISIN · INE082A01010 LEI · 254900JKFI2P8L1G9S54 BSE.NS Manufacturing
Open in API
Filings indexed 549 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS KOPRAN

About Kopran Ltd.

https://www.kopran.com/

Kopran Ltd. is an integrated organization specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms. The company maintains a significant focus on semi-synthetic penicillins and cephalosporins, alongside a diverse portfolio covering therapeutic areas such as cardiovascular health, diabetes management, and anti-infectives. Operating through advanced manufacturing facilities that adhere to international quality benchmarks, the entity provides a vertically integrated supply chain. Its core activities encompass chemical synthesis and the production of oral solids and dry powder injectables. With a dedicated emphasis on research and development, the company serves a global clientele, focusing on high-quality medicinal solutions and process optimization.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the year ended March 31, 2026
Regulatory Filings Classification · 90% confidence The document is a Secretarial Compliance Report prepared by a Practicing Company Secretary under SEBI (LODR) Regulations, providing attestations on regulatory compliance and disclosures. It is an officer certification/compliance attestation rather than a financial report, management discussion, or listing of voting results. As a regulatory compliance filing, it falls under the fallback category for general regulatory announcements or compliance documents. Therefore, it should be classified as Regulatory Filings (RNS).
2026-05-22 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 85% confidence The document is a short letter pursuant to SEBI LODR Regulation 47, enclosing a newspaper advertisement of the audited standalone and consolidated financial results for Q4 and the year ended March 31, 2026. It does not contain the full financial statements, but merely announces that the results have been published in newspapers and are attached. Under the “menu vs. meal” rule, this is a publication announcement of a report rather than the report itself.
2026-05-21 English
Newspaper Advertisement for the Q4 Results FY 2025-26
Report Publication Announcement Classification · 90% confidence The document is a letter to stock exchanges under SEBI LODR Regulation 47 stating that the newspaper advertisement of the audited standalone and consolidated financial results for the quarter/year ended March 31, 2026 has been published and is enclosed. It does not itself contain full financial statements but simply announces and encloses the newspaper publication of results, fitting the definition of a Report Publication Announcement.
2026-05-21 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is an Investor Presentation as indicated by the cover “Investor Presentation on Audited Financial Results for Fourth Quarter and Financial Year ended March 31, 2026,” and it contains slide-style material such as financial highlights, operational performance, business overview, strategy, and governance. It is not an earnings press release, transcript, or standalone report, but a detailed presentation for investors. Therefore, it should be classified as Investor Presentation (IP).
2026-05-20 English
Investor presentation for 2026.
Investor Presentation Classification · 86% confidence The document is a letter under SEBI Regulation 30 transmitting an “Investor Presentation” on the audited financial results for Q4 and FY 2025-26, followed by a slide deck of financial highlights, operational performance, business overview, strategy, governance, etc. This is clearly an investor presentation rather than the report itself or an earnings summary. Therefore it should be classified as an Investor Presentation (IP).
2026-05-20 English
Standalone and Consolidated Audited Financial result for the Fourth quarter and Year ended on March 31, 2026.
Interim / Quarterly Report Classification · 90% confidence The document is a stock‐exchange filing under SEBI’s LODR Regulations 30 and 33 detailing the Board meeting outcome held May 19, 2026, which (1) approves and encloses the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, (2) includes the full set of financial tables (P/L, OCI, Assets & Liabilities) and auditor’s report, and (3) recommends a dividend and appointment of a director. It is more than a brief earnings release (ER) because it contains the actual financial statements and notes. It is not a pure audit opinion note (AR) nor a simple announcement (RPA), but a periodical report with substantive financial data, thus fitting the Interim/Quarterly Report category. FY 2026
2026-05-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.